Riskpilot← Back to searchSign inGet full accessUtslussen Vård AB
ABActiveOrg 5567408637Vaksalagatan 24 D 2trOther residential care activities n.e.c. · NACE 8799Est. 200715 employees
Revenue 2025
SEK 25,8M
+3% vs 2024
EBITDA margin
16.1%
+19% vs 2024
Equity ratio
83.4%
Financial strength
Net profit 2025
SEK 3,3M
+19% vs 2024
| Revenue | SEK 25,8M | +3% |
| EBITDA | SEK 4,2M | +19% |
| Net profit | SEK 3,3M | +19% |
| Total assets | SEK 12M | +12% |
| Equity | SEK 10M | +16% |
| Employees | 15 | — |
Legal name
Utslussen Vård AB
Org number
5567408637
Legal form
Aktiebolag
NACE code
8799 · Other residential care activities n.e.c.
Founded
24 oktober 2007
Share capital
SEK 100 000
Employees
15 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva vård och öppenvård med träningsboende för ungdomar, restaurang- och caféverksamhet samt därmed förenlig verksamhet.
Address
Vaksalagatan 24 D 2tr
Email
info@utslussen.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 26 425 | 25 842 | 22 778 | 25 048 | 25 831 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 6 394 | 5 553 | 2 536 | 3 510 | 4 170 |
| Depreciation & amort. | −108 | −99 | −6 | −107 | −121 |
| EBIT | 6 286 | 5 454 | 2 530 | 3 403 | 4 049 |
| Net financials | −3 | — | 10 | 67 | 84 |
| Profit before tax | 6 311 | 5 474 | 2 339 | 3 487 | 4 153 |
| Tax | −1 358 | −1 131 | −486 | −717 | −856 |
| Net profit | 4 953 | 4 343 | 1 853 | 2 770 | 3 297 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 9 242 | 9 304 | 9 447 | 10 721 | 11 970 |
| Equity | 5 618 | 5 461 | 7 314 | 8 584 | 9 981 |
| Long-term debt | 2 000 | 2 050 | 0 | 0 | 0 |
| Short-term debt | 1 345 | 1 534 | 1 674 | 1 695 | 1 567 |
| Total debt | 3 345 | 3 584 | 1 674 | 1 695 | 1 567 |
EBITDA margin
16.1%
This company
15.8%
Market median
+2% vs market
20212025
Equity ratio
83.4%
This company
38.2%
Market median
+118% vs market
20212025
Return on equity
33.0%
This company
18.4%
Market median
+79% vs market
20212025
Net profit margin
12.8%
This company
8.1%
Market median
+58% vs market
20212025
Asset turnover
2.16×
This company
1.12×
Market median
+93% vs market
20212025
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DP Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tempus Novum Holding AB
Utslussen Vård AB Board members of Utslussen Vård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dag Peter Zetterling | Audit | 0 companies |
| Pia Anneli Lindesjö | Deputy Board Member | 0 companies |
| Fabian Afshin Lindesjö | Board of Directors | 0 companies |